FAM
OXFD

Fred Alger Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Fred Alger Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,000
Closed -$155K – 580
2017
Q1 		$155K Buy
+10,000
New +$143K ﹤0.01% 387

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fred Alger Management's OXFD Position: Q2 2017 in Review

Fred Alger Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2017, closing a stake of 10,000 shares — an estimated $155K sold.

Fred Alger Management first reported a position in OXFD in Q1 2017 and held it in 1 quarter. The position peaked at $155K in Q1 2017. 75 funds tracked by Wall St. Rank hold OXFD as of Q2 2017.

  • Fred Alger Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2017 after selling out during the quarter.
  • Fred Alger Management sold 10,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2017, an estimated $155K.
  • Fred Alger Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 1 quarter.
  • Fred Alger Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $155K in Q1 2017.
  • 75 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2017.

Based on Fred Alger Management's 13F filing for Q2 2017, filed 14 Aug 2017.